Rapid weight loss is a known risk factor for gallstone formation, as it alters the balance of bile components
Currently, common clinical GLP-1RAs include exenatide and exenatide-LAR [34,35,36,37,38,39,40], lixisenatide [41,42,43,44], beinaglutide [45], liraglutide [46,47,48,49,50,51,52,53], semaglutide [54,55,56,57,58], albiglutide [59,60,61], dulaglutide [62,63,64], oral semaglutide [58, 65,66,67], PEG-loxenatide [68] and tirzepatide [68,69,70,71,72,73] (Table 1)
Weigh daily during this period and track the weekly average
[1] [6] Secondly, it suppresses the release of glucagon, a hormone that raises blood glucose levels
Thats because GLP-1 receptors are proteins found on cell surfaces throughout the body, meaning anywhere one appears, the medication can make a difference